Display Settings:

Format

Send to:

Choose Destination
    Mol Genet Metab. 2009 Feb;96(2):73-6. Epub 2008 Dec 10.

    Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?

    Source

    Division of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, Que. H3T1C5, Canada.

    Abstract

    INTRODUCTION:

    No consensus exists on the minimal dose of enzyme replacement therapy (ERT) effective to maintain therapeutic goals in pediatric Gaucher patients.

    OBJECTIVE:

    Evaluate the efficacy of low dosage ERT to maintain treatment goals.

    RESULTS:

    Six patients had a maintenance dose of 30-35U/kg/month. All patients, with the exception of one L444P/L444P homozygote, maintained therapeutic goals.

    DISCUSSION:

    A low maintenance dose may be adequate in most pediatric patients. L444P homozygotes may require a higher maintenance dosage.

    PMID:
    19083253
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk